Q2 2023 · 13F-HR
BRAIDWELL LPholdings as filed
Filed 2023-08-14 · accession 0001420506-23-001695
$3.06B
Reported value
81
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 40131MAB5 | GH 0 11/15/27 | GUARDANT HEALTH INC | $193.1M | 6.31% | 268,252,000 | Common | SOLE |
| 30063PAC9 | EXAS 0.375 03/01/28 | EXACT SCIENCES CORP | $134.7M | 4.40% | 131,000,000 | Common | SOLE |
| 67011XAB9 | NVCR 0 11/01/25 | NOVOCURE LTD | $118.2M | 3.86% | 135,834,000 | Common | SOLE |
| 63009RAD1 | — | NANOSTRING TECHNOLOGIES INC | $115.4M | 3.77% | 145,520,000 | Common | SOLE |
| 04351PAD3 | ASND 2.25 04/01/28 | ASCENDIS PHARMA A/S | $113.2M | 3.70% | 124,000,000 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $101.1M | 3.30% | 128,338,000 | Common | SOLE |
| 64157FAC7 | — | NEVRO CORP | $100.9M | 3.30% | 109,251,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $88.0M | 2.88% | 933,362 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $86.0M | 2.81% | 1,722,353 | Common | SOLE |
| 02081GAB8 | ATEC 0.75 08/01/26 | ALPHATEC HLDGS INC | $82.4M | 2.69% | 70,750,000 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $79.2M | 2.59% | 224,030 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $74.4M | 2.43% | 1,044,392 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $70.4M | 2.30% | 1,828,353 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $56.1M | 1.83% | 1,152,851 | Common | SOLE |
| 24344T101 | DCPHEUR | DECIPHERA PHARMACEUTICALS IN | $51.3M | 1.68% | 3,646,419 | Common | SOLE |
| 761299AB2 | TVTX 2.5 09/15/25 | TRAVERE THERAPEUTICS INC | $50.5M | 1.65% | 56,031,000 | Common | SOLE |
| 670704AJ4 | GMED 0.375 03/15/25 | NUVASIVE INC | $50.1M | 1.64% | 55,323,000 | Common | SOLE |
| 462222AD2 | IONS 0 04/01/26 | IONIS PHARMACEUTICALS INC | $50.0M | 1.63% | 52,740,000 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $49.9M | 1.63% | 478,557 | Common | SOLE |
| 23345J104 | — | DICE THERAPEUTICS INC | $47.8M | 1.56% | 1,029,901 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $46.0M | 1.50% | 1,143,865 | Common | SOLE |
| 64157F103 | NVROEUR | NEVRO CORP | $45.2M | 1.48% | 1,776,368 | Common | SOLE |
| 48576UAA4 | — | KARYOPHARM THERAPEUTICS INC | $43.0M | 1.41% | 65,976,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $42.3M | 1.38% | 123,820 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $40.6M | 1.33% | 1,543,162 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $40.1M | 1.31% | 3,361,813 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $38.8M | 1.27% | 717,050 | Common | SOLE |
| 10806XAD4 | BBIO 2.25 02/01/29 | BRIDGEBIO PHARMA INC | $38.6M | 1.26% | 62,294,000 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $38.4M | 1.25% | 556,301 | Common | SOLE |
| 457669AA7 | — | INSMED INC | $38.0M | 1.24% | 39,963,000 | Common | SOLE |
| 69913P105 | FNAUSD | PARAGON 28 INC | $37.9M | 1.24% | 2,136,122 | Common | SOLE |
| 64049MAB6 | NEO 0.25 01/15/28 | NEOGENOMICS INC | $36.1M | 1.18% | 48,678,000 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $34.7M | 1.13% | 121,942 | Common | SOLE |
| 68752L100 | KIDS | ORTHOPEDIATRICS CORP | $33.4M | 1.09% | 761,208 | Common | SOLE |
| 690145107 | OMGBP | OUTSET MED INC | $31.9M | 1.04% | 1,460,368 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $30.1M | 0.98% | 2,901,194 | Common | SOLE |
| 05465P101 | AXNX* | AXONICS INC | $29.0M | 0.95% | 573,791 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $28.7M | 0.94% | 1,206,300 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $28.3M | 0.93% | 241,399 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $28.1M | 0.92% | 468,027 | Common | SOLE |
| 415858109 | HROW | HARROW HEALTH INC | $27.7M | 0.90% | 1,452,538 | Common | SOLE |
| 64049MAA8 | — | NEOGENOMICS INC | $26.3M | 0.86% | 28,000,000 | Common | SOLE |
| 03236MAJ0 | — | AMYRIS INC | $26.2M | 0.86% | 137,850,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $24.8M | 0.81% | 4,131,315 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $23.5M | 0.77% | 1,154,423 | Common | SOLE |
| 23306J101 | — | DBV TECHNOLOGIES S A | $23.0M | 0.75% | 12,107,785 | Common | SOLE |
| 89422GAA5 | TVTX 2.25 03/01/29 | TRAVERE THERAPEUTICS INC | $22.8M | 0.75% | 28,350,000 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $22.7M | 0.74% | 65,844 | Common | SOLE |
| 452327AK5 | — | ILLUMINA INC | $22.6M | 0.74% | 22,645,000 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $22.4M | 0.73% | 1,804,700 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $22.2M | 0.73% | 1,038,310 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $21.5M | 0.70% | 1,249,246 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $20.5M | 0.67% | 1,908,865 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $19.7M | 0.64% | 2,791,880 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $18.9M | 0.62% | 5,954,273 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $18.4M | 0.60% | 984,400 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $17.9M | 0.58% | 728,549 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $16.1M | 0.53% | 1,842,352 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $15.5M | 0.51% | 1,377,872 | Common | SOLE |
| 46185LAB9 | — | INVITAE CORP | $15.0M | 0.49% | 16,781,000 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $14.2M | 0.47% | 27,300 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $13.9M | 0.45% | 843,087 | Common | SOLE |
| 457985AM1 | IART 0.5 08/15/25 | INTEGRA LIFESCIENCES HLDGS C | $13.3M | 0.43% | 14,500,000 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $13.3M | 0.43% | 55,400 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $13.1M | 0.43% | 999,362 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $13.0M | 0.43% | 92,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $11.7M | 0.38% | 650,312 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $11.3M | 0.37% | 487,520 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $10.4M | 0.34% | 500,000 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $9.7M | 0.32% | 270,000 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $9.4M | 0.31% | 1,249,900 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $9.4M | 0.31% | 550,300 | Common | SOLE |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $8.7M | 0.28% | 240,625 | Common | SOLE |
| 81181C104 | — | SEAGEN INC | $8.2M | 0.27% | 42,497 | Common | SOLE |
| 00847G705 | AGENEUR | AGENUS INC | $7.5M | 0.25% | 4,697,930 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $7.4M | 0.24% | 4,122,900 | Common | SOLE |
| 232109AD0 | — | CUTERA INC | $7.2M | 0.24% | 11,500,000 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $4.4M | 0.14% | 648,451 | Common | SOLE |
| 457669AB5 | INSM 0.75 06/01/28 | INSMED INC | $3.0M | 0.10% | 3,500,000 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $1.2M | 0.04% | 895,949 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HLDGS INC | $457,249 | 0.01% | 25,431 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.